Carcinogenic and anticancer activities of microbiota-derived secondary bile acids

Secondary bile acids (SBAs), which are metabolites produced by gut microbiota, have been implicated in both carcinogenic and anticancer processes. This review explores the dual role of SBAs, focusing on their molecular mechanisms and biological effects. The carcinogenic activities of SBAs include DN...

Full description

Saved in:
Bibliographic Details
Main Authors: Mobina Kouhzad, Friedrich Götz, Tahereh Navidifar, Elahe Taki, Mahsa Ghamari, Roghayeh Mohammadzadeh, Maryam Seyedolmohadesin, Narjess Bostanghadiri
Format: Article
Language:English
Published: Frontiers Media S.A. 2025-01-01
Series:Frontiers in Oncology
Subjects:
Online Access:https://www.frontiersin.org/articles/10.3389/fonc.2025.1514872/full
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1832582948396728320
author Mobina Kouhzad
Friedrich Götz
Tahereh Navidifar
Elahe Taki
Mahsa Ghamari
Roghayeh Mohammadzadeh
Maryam Seyedolmohadesin
Narjess Bostanghadiri
author_facet Mobina Kouhzad
Friedrich Götz
Tahereh Navidifar
Elahe Taki
Mahsa Ghamari
Roghayeh Mohammadzadeh
Maryam Seyedolmohadesin
Narjess Bostanghadiri
author_sort Mobina Kouhzad
collection DOAJ
description Secondary bile acids (SBAs), which are metabolites produced by gut microbiota, have been implicated in both carcinogenic and anticancer processes. This review explores the dual role of SBAs, focusing on their molecular mechanisms and biological effects. The carcinogenic activities of SBAs include DNA damage, promotion of oxidative stress, and modulation of signaling pathways that drive tumorigenesis. Conversely, some SBAs exhibit anticancer properties by inducing apoptosis, inhibiting cell proliferation, and modulating immune responses. The article also discusses the complex interplay between SBAs and the host’s genetic and environmental factors, highlighting potential therapeutic implications and the need for targeted strategies to mitigate risks while harnessing beneficial effects. A comprehensive understanding of the delicate equilibrium between the deleterious and salutary impacts of SBAs has the potential to facilitate the development of innovative cancer prevention and treatment methodologies.
format Article
id doaj-art-5db64e328a4d413b8f21e3bbc0b15ce9
institution Kabale University
issn 2234-943X
language English
publishDate 2025-01-01
publisher Frontiers Media S.A.
record_format Article
series Frontiers in Oncology
spelling doaj-art-5db64e328a4d413b8f21e3bbc0b15ce92025-01-29T05:21:18ZengFrontiers Media S.A.Frontiers in Oncology2234-943X2025-01-011510.3389/fonc.2025.15148721514872Carcinogenic and anticancer activities of microbiota-derived secondary bile acidsMobina Kouhzad0Friedrich Götz1Tahereh Navidifar2Elahe Taki3Mahsa Ghamari4Roghayeh Mohammadzadeh5Maryam Seyedolmohadesin6Narjess Bostanghadiri7Department of Genetics, Faculty of Science, Islamic Azad University North Tehran Branch, Tehran, IranDepartment of Microbial Genetics, Interfaculty Institute of Microbiology and Infection Medicine Tübingen (IMIT), University of Tübingen, Tübingen, GermanyDepartment of Basic Sciences, Shoushtar Faculty of Medical Sciences, Shoushtar, IranDepartment of Microbiology, School of Medicine, Kermanshah University of Medical Science, Kermanshah, IranDepartment of Pathobiology, School of Public Health, Tehran University of Medical Sciences, Tehran, IranDepartment of Microbiology and Virology, School of Medicine, Mashhad University of Medical Sciences, Mashhad, IranDepartment of Genetics, Faculty of Advanced Science and Technology, Tehran Medical Sciences, Azad University, Tehran, IranResearch Center for Clinical Virology, Tehran University of Medical Sciences, Tehran, IranSecondary bile acids (SBAs), which are metabolites produced by gut microbiota, have been implicated in both carcinogenic and anticancer processes. This review explores the dual role of SBAs, focusing on their molecular mechanisms and biological effects. The carcinogenic activities of SBAs include DNA damage, promotion of oxidative stress, and modulation of signaling pathways that drive tumorigenesis. Conversely, some SBAs exhibit anticancer properties by inducing apoptosis, inhibiting cell proliferation, and modulating immune responses. The article also discusses the complex interplay between SBAs and the host’s genetic and environmental factors, highlighting potential therapeutic implications and the need for targeted strategies to mitigate risks while harnessing beneficial effects. A comprehensive understanding of the delicate equilibrium between the deleterious and salutary impacts of SBAs has the potential to facilitate the development of innovative cancer prevention and treatment methodologies.https://www.frontiersin.org/articles/10.3389/fonc.2025.1514872/fullsecondary bile acidscarcinogenicanticancermicrobiotabile acids
spellingShingle Mobina Kouhzad
Friedrich Götz
Tahereh Navidifar
Elahe Taki
Mahsa Ghamari
Roghayeh Mohammadzadeh
Maryam Seyedolmohadesin
Narjess Bostanghadiri
Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
Frontiers in Oncology
secondary bile acids
carcinogenic
anticancer
microbiota
bile acids
title Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
title_full Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
title_fullStr Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
title_full_unstemmed Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
title_short Carcinogenic and anticancer activities of microbiota-derived secondary bile acids
title_sort carcinogenic and anticancer activities of microbiota derived secondary bile acids
topic secondary bile acids
carcinogenic
anticancer
microbiota
bile acids
url https://www.frontiersin.org/articles/10.3389/fonc.2025.1514872/full
work_keys_str_mv AT mobinakouhzad carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT friedrichgotz carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT taherehnavidifar carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT elahetaki carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT mahsaghamari carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT roghayehmohammadzadeh carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT maryamseyedolmohadesin carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids
AT narjessbostanghadiri carcinogenicandanticanceractivitiesofmicrobiotaderivedsecondarybileacids